Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.

[1]  Horst Olschewski,et al.  Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension , 2006 .

[2]  W. Seeger,et al.  Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension. Author's reply , 2006 .

[3]  R. Benza,et al.  Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. , 2005, American Journal of Respiratory and Critical Care Medicine.

[4]  T. Hunt,et al.  Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers , 2004, Journal of cardiovascular pharmacology.

[5]  S. Rich,et al.  Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. , 2004, Chest.

[6]  L. Rubin,et al.  Pulmonary arterial hypertension: a look to the future. , 2004, Journal of the American College of Cardiology.

[7]  R. Barst,et al.  Prostanoid therapy for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[8]  T. Hunt,et al.  Pharmacokinetics of Treprostinil Sodium Administered by 28‐Day Chronic Continuous Subcutaneous Infusion , 2004, Journal of clinical pharmacology.

[9]  W. Seeger,et al.  Prostacyclin and its analogues in the treatment of pulmonary hypertension. , 2004, Pharmacology & therapeutics.

[10]  T. Hunt,et al.  Absolute Bioavailability and Pharmacokinetics of Treprostinil Sodium Administered by Acute Subcutaneous Infusion , 2004, Journal of clinical pharmacology.

[11]  H. Ghofrani,et al.  Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. , 2003, Chest.

[12]  S. Rich,et al.  Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension , 2003, Journal of cardiovascular pharmacology.

[13]  W. Seeger,et al.  Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.

[14]  S. Rich,et al.  Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[15]  T. Kaptchuk.  The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? , 2001, Journal of clinical epidemiology.

[16]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.